The Carlyle Group related stories
All articles and analysis
Carlyle: GPs and LPs have reached ‘equilibrium’ over feesThat’s because private equity firms are increasingly transparent with LPs about the fees they charge, Carlyle’s co-founder and co-CEO David Rubenstein said during a second-quarter earnings call with analysts.
- KKR to exit Australia’s GenesisCare
Having grown GenesisCare’s business in Europe through acquisitions and partnerships, KKR is selling its 45% stake in the Sydney-based healthcare provider to China Resources Group and Macquarie Capital in a deal that reportedly values the company at A$1.7bn.
- Carlyle re-lists Japanese medical administration business
The New York-headquartered firm originally acquired Solasto Corporation in 2012.
- US PE stays mum on Brexit outcome
US-based GPs and LPs are choosing to wait and see what unfolds with Brexit, rather than react.
- Report: Korea’s military fund ups alternatives target
The $8bn Military Mutual Aid Association is going deeper into alternatives and investing more overseas.
- CPPIB appoints Orida as head of PE in Asia
Deborah Orida was previously head of relationship investments at CPPIB’s Hong Kong office.
- European deal value plummets in H1 2016
Values halved from H2 2015 to €25.6bn as the market ‘normalises’ and mega deals slow, according to research from CMBOR.
- Carlyle hires China healthcare veteran
Jesse Wu will advise the firm on its Asia-Pacific portfolio, which contains Chinese private hospital group Zhongmei Healthcare Group and medical device manufacturer MicroPort Scientific.
- Carlyle names Australia and New Zealand MD
David Bluff replaces former managing director Simon Moore at the end of the month.
- General Atlantic appoints former Carlyle MD as China head
Eric Zhang was previously a global partner and managing director at Carlyle.